Here are three major trials
The Atlanta Journal-Constitution CenterWatch reported the following clinical
trials:
Multiple Sclerosis - A research study for patients with relapsing MS, not currently on therapy or who prefer not to be on interferon therapies, who haven’t been treated with Copaxone. Approximately 150 male and female patients (100 active and 50 placebo), aged 18 to 55, with relapsing MS and at least one but no more than 10 total Gd-enhancing lesions on cranial MRI scans during the run-in phase may be eligible. Research sites located throughout the U.S. and Canada. For Information, visit
www.centerwatch.com/patient/studies/cat102.html.
COPD (Chronic Obstructive Pulmonary Disease) - North Shore University Hospital is recruiting people with chronic obstructive pulmonary disease
(COPD) to participate in a research study investigating an experimental drug to be used for COPD. To be eligible for this study, volunteers must be at least 40 and be diagnosed with COPD. Research site located in New Hyde Park, NY. For Information, visit
www.centerwatch.com/patient/studies/cat44.html.
Depression (major/severe) - This is a major depressive disorder (MDD) research study of patients with decreased energy, pleasure, and interests.
Volunteers must have a primary diagnosis of MDD with current duration lasting 12 weeks but no greater than two years and be in generally good health. Research sites located throughout the U.S. For information, visit http://www.centerwatch.com/patient/studies/cat44.html.